RVL Pharmaceuticals plc Operating Expenses
RVL Pharmaceuticals plc reported Operating Expenses of $28.33 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-08-14
- RVL Pharmaceuticals plc operating expenses for the quarter ending 2023-06-30 was $28.33M, a 32.74% increase year-over-year.
- RVL Pharmaceuticals plc operating expenses for the quarter ending 2023-03-31 was $16.82M, a 31.88% decline year-over-year.
- RVL Pharmaceuticals plc operating expenses for the quarter ending 2022-12-31 was $31.80M, a 28.02% increase year-over-year.
- RVL Pharmaceuticals plc operating expenses for the quarter ending 2022-09-30 was $21.42M, a 18.30% decline year-over-year.
- RVL Pharmaceuticals plc operating expenses for fiscal 2022 was $99.25M, a 2.95% decline from fiscal 2021.
- RVL Pharmaceuticals plc operating expenses for fiscal 2021 was $102.27M, a 11.16% decline from fiscal 2020.
- RVL Pharmaceuticals plc operating expenses for fiscal 2020 was $115.12M.
- RVL Pharmaceuticals plc operating expenses for fiscal 2018 was $222.16M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $28.33M 10-Q · filed 2023-08-14 | $45.16M 10-Q · filed 2023-08-14 | $76.95M derived: sum of 3 quarters · filed 2023-08-14 | $98.37M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $16.82M 10-Q · filed 2023-05-11 | $48.62M derived: sum of 2 quarters · filed 2023-05-11 | $70.04M derived: sum of 3 quarters · filed 2023-05-11 | $91.38M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $53.21M derived: sum of 2 quarters · filed 2023-03-20 | $74.56M derived: sum of 3 quarters · filed 2023-08-14 | $99.25M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $21.42M 10-Q · filed 2022-11-10 | $42.76M derived: sum of 2 quarters · filed 2023-08-14 | $67.46M 10-Q · filed 2022-11-10 | $92.30M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $21.34M 10-Q · filed 2023-08-14 | $46.04M 10-Q · filed 2023-08-14 | $70.88M derived: sum of 3 quarters · filed 2023-08-14 | $97.09M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $24.70M 10-Q · filed 2023-05-11 | $49.53M derived: sum of 2 quarters · filed 2023-05-11 | $75.75M derived: sum of 3 quarters · filed 2023-05-11 | $106.73M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $24.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $51.05M derived: sum of 2 quarters · filed 2023-03-20 | $82.03M derived: sum of 3 quarters · filed 2023-03-20 | $102.27M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $26.22M 10-Q · filed 2022-11-10 | $57.20M derived: sum of 2 quarters · filed 2022-11-10 | $77.44M 10-Q · filed 2022-11-10 | $128.18M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $30.98M 10-Q · filed 2022-08-11 | $50.13M 10-Q · filed 2022-08-11 | $50.14M 10-Q · filed 2021-08-16 | $101.96M derived: sum of 3 quarters · filed 2022-08-11 | $125.10M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $19.16M 10-Q · filed 2022-05-12 | $22.23M 10-Q · filed 2021-05-13 | $70.98M derived: sum of 2 quarters · filed 2022-05-12 | $94.12M derived: sum of 3 quarters · filed 2022-05-12 | $111.41M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $51.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $74.97M derived: sum of 2 quarters · filed 2022-03-30 | $92.26M derived: sum of 3 quarters · filed 2022-03-30 | $115.12M 10-K · filed 2022-03-30 | $173.84M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $23.14M 10-Q · filed 2021-11-15 | $46.81M 10-Q · filed 2020-11-10 | $40.43M derived: sum of 2 quarters · filed 2021-11-15 | $63.29M 10-Q · filed 2021-11-15 | $99.62M 10-Q · filed 2020-11-10 | -$156.08M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $17.29M 10-Q · filed 2021-08-16 | $25.94M 10-Q · filed 2020-08-11 | $39.76M 10-Q · filed 2021-08-16 | $52.81M 10-Q · filed 2020-08-11 | -$179.22M derived: sum of 3 quarters · filed 2021-09-08 | -$18.07M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $26.86M 10-Q · filed 2021-05-13 | -$196.51M derived: sum of 2 quarters · filed 2021-09-08 | -$35.36M derived: sum of 3 quarters · filed 2021-09-08 | $121.28M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$223.37M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$62.22M derived: sum of 2 quarters · filed 2021-09-08 | $94.42M derived: sum of 3 quarters · filed 2021-09-08 | $125.84M 8-K · filed 2021-09-08 | $409.10M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $161.15M 10-Q · filed 2020-11-10 | $161.15M 10-Q · filed 2019-11-14 | $317.79M derived: sum of 2 quarters · filed 2020-11-10 | $349.21M 10-Q · filed 2020-11-10 | $349.21M 10-Q · filed 2019-11-14 | $484.80M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $156.64M 10-Q · filed 2020-08-11 | $156.64M 10-Q · filed 2019-08-08 | $188.06M 10-Q · filed 2020-08-11 | $188.06M 10-Q · filed 2019-08-08 | $323.65M derived: sum of 3 quarters · filed 2020-08-11 | $359.24M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $31.42M 10-Q · filed 2020-05-12 | $31.42M 10-Q · filed 2019-05-09 | $167.01M derived: sum of 2 quarters · filed 2020-05-12 | $202.60M derived: sum of 3 quarters · filed 2020-05-12 | $228.14M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $135.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $171.18M derived: sum of 2 quarters · filed 2020-03-19 | $196.72M derived: sum of 3 quarters · filed 2020-03-19 | $222.16M 10-K · filed 2020-03-19 | $227.23M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $35.59M 10-Q · filed 2019-11-14 | $36.93M 10-Q · filed 2018-11-08 | $61.13M derived: sum of 2 quarters · filed 2019-11-14 | $86.57M 10-Q · filed 2019-11-14 | $89.91M 10-Q · filed 2018-11-08 | $126.71M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-06-30 | $25.54M 10-Q · filed 2019-08-08 | $52.78M 10-Q · filed 2019-08-08 | $91.12M derived: sum of 3 quarters · filed 2019-12-20 | $141.62M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-03-31 | $27.34M 10-Q · filed 2019-05-09 | $65.58M derived: sum of 2 quarters · filed 2019-12-20 | $116.08M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2017-12-31 | $38.25M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $88.74M derived: sum of 2 quarters · filed 2019-12-20 | $170.18M 8-K · filed 2019-12-20 | $172.63M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $50.50M 10-Q · filed 2018-11-08 | $131.94M 10-Q · filed 2018-11-08 |